{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:36:42Z","timestamp":1761586602014,"version":"build-2065373602"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>T-cell receptor (TCR) repertoire diversity has been implicated in the progression and prognosis of multiple myeloma (MM). This study aimed to evaluate the association between T-cell clonality, immune response, and clinical outcomes in patients with plasma cell dyscrasias using next-generation sequencing of the TCR \u03b2 chain (TCRB). TCRB sequencing was performed on peripheral blood samples from patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and newly diagnosed multiple myeloma (MM). Healthy individuals served as controls. No significant differences in TCR repertoire diversity were observed between healthy individuals and those with MGUS, SMM or MM after adjusting for age. Furthermore, TCR diversity did not correlate with treatment response in newly diagnosed MM or SMM patients. However, machine learning analysis revealed distinct TCR clusters differentially abundant between healthy individuals and those with plasma cell dyscrasias, exhibiting different amino acid properties. These findings suggest that shared T-cell receptor specificities among patients with plasma cell dyscrasias reflect underlying differences in antigen recognition and underscore the need for further studies to unravel the functional and clinical significance of these distinct immune signatures.<\/jats:p>","DOI":"10.1371\/journal.pone.0334053","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:31:53Z","timestamp":1761586313000},"page":"e0334053","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controls"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-8836","authenticated-orcid":true,"given":"David G.","family":"Coffey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.","family":"Theoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-415X","authenticated-orcid":true,"given":"Andrea C.","family":"Baines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dickran","family":"Kazandjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"9","key":"pone.0334053.ref001","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.3390\/ijms23095242","article-title":"The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches","volume":"23","author":"I Lagreca","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0334053.ref002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-immunol-032414-112334","article-title":"T cell antigen receptor recognition of antigen-presenting molecules","volume":"33","author":"J Rossjohn","year":"2015","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"pone.0334053.ref003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2141.2000.02131.x","article-title":"T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells","volume":"110","author":"M Raitakari","year":"2000","journal-title":"Br J Haematol"},{"issue":"6","key":"pone.0334053.ref004","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cncr.21746","article-title":"Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic\/Th1 T cells demonstrating a squed TCR-Vbeta repertoire","volume":"106","author":"M P\u00e9rez-Andres","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"pone.0334053.ref005","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V98.9.2817","article-title":"Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment","volume":"98","author":"DM Sze","year":"2001","journal-title":"Blood"},{"issue":"1","key":"pone.0334053.ref006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease","volume":"134","author":"M Strioga","year":"2011","journal-title":"Immunology"},{"issue":"10","key":"pone.0334053.ref007","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/1042819031000097438","article-title":"Clonal cytotoxic T cells in myeloma","volume":"44","author":"DMY Sze","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"pone.0334053.ref008","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3109\/10428190903216804","article-title":"Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma","volume":"50","author":"RD Brown","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"pone.0334053.ref009","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/eji.1830270919","article-title":"T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden","volume":"27","author":"E Halapi","year":"1997","journal-title":"Eur J Immunol"},{"issue":"1","key":"pone.0334053.ref010","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1038\/s41467-023-40966-8","article-title":"Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma","volume":"14","author":"DG Coffey","year":"2023","journal-title":"Nat Commun"},{"issue":"11","key":"pone.0334053.ref011","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/jamaoncol.2021.3971","article-title":"Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial","volume":"7","author":"D Kazandjian","year":"2021","journal-title":"JAMA Oncol"},{"issue":"6","key":"pone.0334053.ref012","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaoncol.2015.2010","article-title":"Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma","volume":"1","author":"N Korde","year":"2015","journal-title":"JAMA Oncol"},{"issue":"12","key":"pone.0334053.ref013","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jamaoncol.2018.5457","article-title":"Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial","volume":"4","author":"D Kazandjian","year":"2018","journal-title":"JAMA Oncol"},{"issue":"12","key":"pone.0334053.ref014","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"SV Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"pone.0334053.ref015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.V110.11.1487.1487","article-title":"Immunoglobulin Free Light Chain Ratio Is an Independent Risk Factor for Progression of Smoldering Multiple Myeloma","volume":"110","author":"A Dispenzieri","year":"2007","journal-title":"Blood"},{"issue":"7","key":"pone.0334053.ref016","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"E P\u00e9rez-Persona","year":"2007","journal-title":"Blood"},{"issue":"20","key":"pone.0334053.ref017","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2014-09-568899","article-title":"Smoldering multiple myeloma","volume":"125","author":"SV Rajkumar","year":"2015","journal-title":"Blood"},{"issue":"12","key":"pone.0334053.ref018","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/bloodadvances.2016003715","article-title":"MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods","volume":"1","author":"M Roshal","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"pone.0334053.ref019","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.3822","article-title":"Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire","volume":"49","author":"RO Emerson","year":"2017","journal-title":"Nat Genet"},{"key":"pone.0334053.ref020","author":"D Hamm","journal-title":"immunoSEQ hsTCRB-V4 Control Data. immuneACCESS. Adaptive Biotechnologies"},{"key":"pone.0334053.ref021","volume-title":"Immunarch: An R Package for Painless Bioinformatics Analysis of T-Cell and B-Cell Immune Repertoires","author":"A Popov","year":"2019"},{"key":"pone.0334053.ref022","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.copbio.2020.07.010","article-title":"T-cell repertoire analysis and metrics of diversity and clonality","volume":"65","author":"J Chiffelle","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"pone.0334053.ref023","article-title":"VDJdb: a curated database of T-cell receptor sequences with known antigen specificity","volume":"46","author":"M Shugay","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"pone.0334053.ref024","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1093\/bioinformatics\/btx286","article-title":"McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences","volume":"33","author":"N Tickotsky","year":"2017","journal-title":"Bioinformatics"},{"issue":"3","key":"pone.0334053.ref025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/bioinformatics\/btz614","article-title":"PIRD: Pan Immune Repertoire Database","volume":"36","author":"W Zhang","year":"2019","journal-title":"Bioinformatics"},{"issue":"5","key":"pone.0334053.ref026","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"CG Kanakry","year":"2016","journal-title":"JCI Insight"},{"issue":"20","key":"pone.0334053.ref027","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"NT Gupta","year":"2015","journal-title":"Bioinformatics"},{"issue":"24","key":"pone.0334053.ref028","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1093\/bioinformatics\/btab446","article-title":"ClusTCR: a python interface for rapid clustering of large sets of CDR3 sequences with unknown antigen specificity","volume":"37","author":"S Valkiers","year":"2021","journal-title":"Bioinformatics"},{"issue":"7661","key":"pone.0334053.ref029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature22976","article-title":"Identifying specificity groups in the T cell receptor repertoire","volume":"547","author":"J Glanville","year":"2017","journal-title":"Nature"},{"issue":"7661","key":"pone.0334053.ref030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature22383","article-title":"Quantifiable predictive features define epitope-specific T cell receptor repertoires","volume":"547","author":"P Dash","year":"2017","journal-title":"Nature"},{"issue":"10","key":"pone.0334053.ref031","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","article-title":"Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening","volume":"38","author":"H Huang","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"1","key":"pone.0334053.ref032","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1038\/s41467-021-25006-7","article-title":"GIANA allows computationally-efficient TCR clustering and multi-disease repertoire classification by isometric transformation","volume":"12","author":"H Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0334053.ref033","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1158\/1078-0432.CCR-19-3249","article-title":"Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers","volume":"26","author":"H Zhang","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:31:58Z","timestamp":1761586318000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334053"}},"subtitle":[],"editor":[{"given":"Jian","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334053","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}